Literature DB >> 19931822

Diagnostic techniques in bloodstream infections: where are we going?

Stefania Stefani1.   

Abstract

Rapid and early detection of bacteria in blood has an important role in the diagnosis of a febrile patient for at least three reasons: to establish the presence of an infection, to reassure the clinician about the chosen empirical therapy and to define antibiotic treatment after isolation of the microorganism and determination of its antibiotic susceptibility. We all agree that blood culture is the gold standard for aetiological diagnosis. However, it has limitations: the time required for bacteria to multiply to a detectable number of cells, the inadequate sensitivity of blood culture for fastidious pathogens and in patients who have previously received antibiotics, or when there is a catheter-related bloodstream infection. We must, however, remember that the current blood culture data constitute an important epidemiological tool on which clinicians can base empirical therapy. Over the past few years many new molecular tests have been developed that are now entering mainstream practice. These tests are more rapid, specific and sensitive; however, there are still some problems: antibiotic susceptibility testing is still lacking, and sometimes they are so sensitive that a skilled operator may be necessary for an accurate interpretation of the results. These new methods are promising, and their performance can only get better as they are increasingly used in clinical microbiological laboratories.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931822     DOI: 10.1016/S0924-8579(09)70558-8

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

1.  Microbial diagnostics in patients with presumed severe infection in the emergency department.

Authors:  S Hettwer; J Wilhelm; M Schürmann; H Ebelt; D Hammer; M Amoury; F Hofmann; A Oehme; D Wilhelms; A S Kekulé; T Klöss; K Werdan
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-02       Impact factor: 0.840

2.  Direct identification of major Gram-negative pathogens in respiratory specimens by respiFISH® HAP Gram (-) Panel, a beacon-based FISH methodology.

Authors:  R Koncan; M Parisato; C Sakarikou; G Stringari; C Fontana; V Favuzzi; M Ligozzi; G Lo Cascio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-29       Impact factor: 3.267

3.  Beacon-based (bbFISH®) technology for rapid pathogens identification in blood cultures.

Authors:  Christina Sakarikou; Martina Parisato; Giuliana Lo Cascio; Carla Fontana
Journal:  BMC Microbiol       Date:  2014-04-22       Impact factor: 3.605

4.  The rapid detection of cefotaxime-resistant Enterobacteriaceae by HPLC.

Authors:  Andrew M Robinson; Natalie J Medlicott; James E Ussher
Journal:  Future Sci OA       Date:  2016-09-09

5.  In-depth analysis of T2Bacteria positive results in patients with concurrent negative blood culture: a case series.

Authors:  Markos Kalligeros; Ioannis M Zacharioudakis; Giannoula S Tansarli; Katerina Tori; Fadi Shehadeh; Eleftherios Mylonakis
Journal:  BMC Infect Dis       Date:  2020-05-07       Impact factor: 3.090

6.  Design of a Tablet Computer App for Facilitation of a Molecular Blood Culture Test in Clinical Microbiology and Preliminary Usability Evaluation.

Authors:  Lasse L Samson; Louise Pape-Haugaard; Michelle C Meltzer; Martin Fuchs; Henrik C Schønheyder; Ole Hejlesen
Journal:  JMIR Mhealth Uhealth       Date:  2016-03-18       Impact factor: 4.773

7.  The Performance of the Four Anaerobic Blood Culture Bottles BacT/ALERT-FN, -FN Plus, BACTEC-Plus and -Lytic in Detection of Anaerobic Bacteria and Identification by Direct MALDI-TOF MS.

Authors:  Mohammed Almuhayawi; Osman Altun; Adam Dilshad Abdulmajeed; Måns Ullberg; Volkan Özenci
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

8.  Acoustic impedance matched buffers enable separation of bacteria from blood cells at high cell concentrations.

Authors:  Pelle Ohlsson; Klara Petersson; Per Augustsson; Thomas Laurell
Journal:  Sci Rep       Date:  2018-06-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.